HYPERFINE INC. - CLA

Hyperfine Reports Second Quarter 2022 Financial Results

10 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Hyperfine to Announce Second Quarter 2022 Financial Results on August 10, 2022

20 Jul 2022 16:15:00 By Nasdaq GlobeNewswire

Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients

14 Jul 2022 09:00:01 By Nasdaq GlobeNewswire

Hyperfine Announces CEO Transition

29 Jun 2022 16:05:00 By Nasdaq GlobeNewswire

Hyperfine Announces Expansion into Australia and New Zealand with Medical Device Registration and Notification

14 Jun 2022 04:10:00 By Nasdaq GlobeNewswire

Hyperfine to Present at the 2022 Jefferies Global Healthcare Conference

25 May 2022 16:10:00 By Nasdaq GlobeNewswire

Hyperfine Reports First Quarter 2022 Financial Results

11 May 2022 16:05:01 By Nasdaq GlobeNewswire

Hyperfine to Announce First Quarter 2022 Financial Results on May 11, 2022

20 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Hyperfine Reports Fourth Quarter and Full Year 2021 Financial Results

23 Mar 2022 16:05:00 By Nasdaq GlobeNewswire

Hyperfine to Announce Fourth Quarter and Full Year 2021 Financial Results

03 Mar 2022 09:00:01 By Nasdaq GlobeNewswire

Hyperfine to Present at the 42nd Annual Cowen Healthcare Conference

01 Mar 2022 16:10:00 By Nasdaq GlobeNewswire

Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities

16 Feb 2022 08:00:01 By Nasdaq GlobeNewswire

Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director

08 Feb 2022 08:00:02 By Nasdaq GlobeNewswire

M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering

19 Jan 2022 08:00:01 By Nasdaq GlobeNewswire

Hyperfine Reports Preliminary Unaudited 2021 Revenue and Swoop® System Installations

10 Jan 2022 07:30:01 By Nasdaq GlobeNewswire